Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Coronary Stents Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In the previous years, there has been significant growth in the coronary stents market size. It is predicted to increase from $11.06 billion in 2024 to $11.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.6%. The expansion during the historic era can be credited to the escalating preference for minimally invasive methods, growth of healthcare accessibility in emerging markets, increase in healthcare spending, rise in percutaneous coronary interventions, and a growing population of cardiologists.

It is predicted that the coronary stents market will experience substantial expansion in coming years, with projections for it to reach $16.4 billion by 2029 with a compound annual growth rate (CAGR) of 8.3%. This upswing during the forecast period is mainly due to an increase in cardiovascular diseases, an ageing populace, heightened awareness surrounding heart health, government backing and funding, and rising incidence of lifestyle-related diseases. The forecast period also signifies important trends such as advancements in stent and imaging technology, strategic alliances and partnerships, novel developments in stent materials, and technological mergers with digital health.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Coronary Stents Market?

The coronary stent market is predicted to expand due to the escalating occurrence of cardiovascular diseases (CVDs). Heart and blood vessel-related disorders such as coronary artery disease, hypertension, heart failure, and stroke fall under the spectrum of cardiovascular diseases. The increase in such diseases is primarily due to factors like an aged population, obesity, diabetes, lack of physical activity, unhealthy diet, and stress. To alleviate cardiovascular diseases, coronary stents are employed to widen or unclog coronary arteries, thus improving heart blood flow and decreasing heart attack risk. For example, according to a report by the American College of Cardiology, a U.S. non-profit medical association, in August 2022, a significant escalation in cardiovascular risk factors is projected between 2025 and 2060 in the U.S. Diabetes is projected to increase by 39.3%, affecting 55 million people, with dyslipidemia increasing by 27.6% to 126 million, hypertension growing by 25.1% to 162 million, and obesity increasing by 18.3% to 126 million. Stroke and heart failure are expected to witness the most substantial escalations among cardiovascular diseases, rising by 33.8% and 33.4% respectively. This is followed by ischemic heart disease rising by 30.7% and heart attacks increasing by 16.9%. Consequently, the accelerating occurrence of cardiovascular diseases (CVDs) is fueling the growth of the coronary stent market.

Which Key Market Segments Comprise the Coronary Stents Market and Drive Its Revenue Growth?

The coronary stentsmarket covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

Which Areas Are Leading Regions in the Coronary Stents Market Expansion Across the Globe?

North America was the largest region in the coronary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theCoronary Stents Market Direction?

Significant players in the coronary stent sector, such as Abbott, are working on breakthrough products that could reduce the requirement for additional procedures in comparison to traditional bare-metal stents. For instance, they’re creating drug-eluting stents, a type of coronary stent coated with medical substances designed to slow down the process of arteries narrowing. They do so by gradually releasing drugs over a specified period. Notably, in May 2024, US-based healthcare firm Abbott unveiled its XIENCE Sierra Everolimus Eluting Coronary Stent System in India, setting it apart with its superior design, innovative delivery system, and unique sizing options, devised for particularly difficult cases. Like all other XIENCE stents, it has a particular coating designed to mitigate the risk of arteries blocking again. Over 120 clinical trials involving above 120,000 patients, confirming its remarkable safety profile, back this stent.

View the full report here:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

How Is the Coronary Stents Market Conceptually Defined?

Coronary stents are small, expandable tubes used to open up narrowed or blocked coronary arteries, which supply blood to the heart muscle. These devices are typically made of metal mesh and are placed during a procedure called percutaneous coronary intervention (PCI), often referred to as angioplasty. The stent is inserted into the artery on a balloon catheter and expanded at the site of the blockage to restore proper blood flow.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18325

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model